Holen Sie sich die Stockscreener-App
31.32
3.09%
-1.00
Finanzdaten der Agios Pharmaceuticals Inc-Aktie (AGIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
115.68%
44.74
|
20.75 | 19.97 | 12.88 | 12.46 |
| Cost Of Revenue |
127.14%
2.996
|
1.319 | 1.879 | 1.679 | 1.702 |
Selling, General, and Administrative
|
6.71%
51.55
|
48.30 | - | - | - |
| Costs And Expenses |
18.75%
155.30
|
130.77 | 141.54 | 129.75 | 139.51 |
| Operating Income/Loss |
0.48%
-110.55
|
-110.03 | -121.58 | -116.87 | -127.06 |
| Net Income/Loss |
1.61%
-100.70
|
-99.11 | -108.04 | -103.43 | -112.02 |
| Basic Average Shares |
1.20%
59.49
|
58.78 | 0.1258 | 58.14 | 57.93 |
| Diluted Average Shares |
1.20%
59.49
|
58.78 | 0.1258 | 58.14 | 57.93 |
| Basic Earnings Per Share |
0.00%
-1.69
|
-1.69 | -1.85 | -1.78 | -1.93 |
| Diluted Earnings Per Share |
0.00%
-1.69
|
-1.69 | -1.85 | -1.78 | -1.93 |
16.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):